Clinical Trial Update: A Study to Compare Elritercept With Epoetin Alfa to Treat Anemia in Adults With Very Low, Low, or Intermediate Risk Myelodysplastic Syndromes (MDS) Who Need Regular Blood Transfusions [Phase 3]

View source ↗

Summary

A Phase 3 clinical trial compares elritercept with epoetin alfa to treat anemia in adults with very low-, low-, or intermediate-risk myelodysplastic syndromes w…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Anemia
• Myelodysplastic Syndromes

Drugs mentioned

• EPOETIN ALFA (EPOETIN ALFA)
• Elritercept (Elritercept)

Snippet

Sponsor: Takeda | Conditions: Myelodysplastic Syndrome, Anemia | Phase 3 | Status: RECRUITING